Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema

References 

1. Alberola TM, Bautista-Llácer R, Fernández E, et al. Preimplantation genetic diagnosis of P450 oxidoreductase deficiency and Huntington Disease using three different molecular approaches simultaneously. J. Assist. Reprod. Genet. 2009;263–271
2. Altarescu G, Eldar Geva T, Brooks B, et al. PGD on a recombinant allele: crossover between the TSC2 gene and ‘linked’ markers impairs accurate diagnosis. Prenat. Diagn. 2008;929–933
3. Altarescu G, Eldar Geva T, Varshower I, et al. Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of the novo mutations. Hum. Reprod. 2009;3225–3229
4. Bork K, Hardt J, Shiketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch. Intern. Med. 2003;1229–1235
5. Burlet P, Gigarel N, Magen M, et al. Single sperm analysis for recurrence risk assessment of spinal muscular atrophy. Eur. J. Hum. Genet. 2010;505–508
6. Cui XF, Li HH, Goradia TM, et al. Single-sperm typing: determination of genetic distance between the G gamma-globin and parathyroid hormone loci by using the polymerase chain reaction and allele-specific oligomers. Proc. Natl. Acad. Sci. USA. 1989;9389–9393
7. Fiorentino F, Biricik A, Nuccitelli A, et al. Strategies and clinical outcome of 250 cycles of preimplantation genetic diagnosis for single gene disorders. Hum. Reprod. 2006;670–684
8. Gigarel N, Frydman N, Burlet P, et al. Preimplantation genetic diagnosis for autosomal recessive polycystic kidney disease. Reprod. BioMed. Online. 2008;152–158
9. Girardet A, Hamamah S, Anahory T, et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol. Hum. Reprod. 2003;111–116
10. Gompels MM, Lock RJ, Abinum M, et al. C1 inhibitor deficiency consensus document. Clin. Exp. Immunol. 2005;379–394
11. Goossens V, Harton G, Moutou C, et al. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum. Reprod. 2009;1786–1810
12. Kakourou G, Dhanjal S, Daphnis D, et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1: detection of crossover between the gene and the linked marker APOC2. Prenat. Diagn. 2007;111–116
13. Malmstrom HS, Hock JM, Sanford C. Dental management of patients with hereditary angioedema: report of case. J. Am. Dent. Assoc. 1985;957–958
14. Renwick PJ, Trussler J, Ostad-Saffari E, et al. Proof of principle and first cases using preimplantation genetic haplotyping – a paradigm shift for embryo diagnosis. Reprod. BioMed. Online. 2006;110–119
15. Spits , Sermon . PGD for monogenic disorders: aspects of molecular biology. Prenat. Diagn. 2009;50–56
16. The Preimplantation Genetic Diagnosis International Society (PGDIS) . Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. Reprod. BioMed. Online. 2008;134–147
17. Thornhill AR, deDie-Smulders CE, Geraedts JP, et al. ESHRE PGD Consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum. Reprod. 2005;35–48
18. Vendrell X, Carrero R, Alberola T, et al. Quality Management system in PGD/PGS: now is the time. J. Assist. Reprod. Genet. 2009;197–204
19. Wilton L, Thornhill A, Traeger-Synodinos J, et al. The causes of misdiagnosis and adverse outcomes in PGD. Hum. Reprod. 2009;1221–1228
20. Zuraw BL, Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J. Allergy Clin. Immunol. 2000;541–546